Ulcerative colitis is an inflammatory bowel disease (IBD) that causes inflammation and ulcers (sores) in the digestive tract. It affects the innermost lining of large intestine (colon) and rectum. Ulcerative colitis treatment usually involves either drug therapy or surgery. Several categories of drugs may be effective in treating ulcerative colitis.
Get Free Sample PDF Copy (Including Full TOC, List of Tables & Figures, Chart) @
Players in the market focusing on introducing safe and effective treatment of ulcerative colitis, which in turn is expected to augment the China ulcerative colitis market growth. For instance, in July 2021, Tillotts Pharma AG launched Asacol 800 mg tablets in China for the treatment of mild to moderate ulcerative colitis.
Furthermore, players in the market are engaged in research and development to launch novel treatment of ulcerative colitis. This in turn is also expected to boost the China ulcerative colitis market growth. For instance, in November 2021, InDex Pharmaceuticals Holding announced the enrolment of first patient in the pivotal phase III study CONCLUDE to evaluate the safety and efficacy of TLR9 agonist cobitolimod as a novel treatment for ulcerative colitis.
The outbreak of COVID-19 has had a severe impact on the growth of China ulcerative colitis market due to the increasing risk of COVID-19 due to drugs of IBD. The pandemic has affected the market in several ways, such as by directly affecting production and demand and by causing disruption in supply chain.
For instance, according to article published in British Medical Journal in March 2021, around 1400 people with inflammatory bowel disease from 47 countries using thiopurine monotherapy and the combination of thiopurines with tumor necrosis factor antagonists were found to be associated with a significantly increased risk of severe COVID-19.
Request PDF Brochure with Latest Insights @
Major players involved in the China ulcerative colitis market are HUTCHMED, Theravance Biopharma, EA Pharma Co., Ltd., Salix Pharmaceuticals, ZERIA Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, InDex Pharmaceuticals Holding AB, Amgen Inc., Pfizer Inc., AstraZeneca, BRISTOL-MYERS SQUIBB, GlaxoSmithKline Plc., Eli Lilly and Company, Arena Pharmaceuticals, F. Hoffmann-La Roche AG, Johnson & Johnson Services, Inc., Celltrion Healthcare, AbbVie, Teva Pharmaceutical Industries, Takeda Pharmaceuticals Company Ltd., and Boehringer Ingelheim International GmbH, among others.
Key players in the market are adopting various inorganic growth strategies to strengthen their market position. For instance, in February 2018, Theravance Biopharma Ireland Ltd. entered into a co-development and commercialization agreement with Janssen Biotech, Inc. for TD-1473 and related back-up compounds for inflammatory intestinal diseases, including ulcerative colitis and Crohn’s disease.
Reasons to buy this China Ulcerative Colitis Market Report
◘ Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging China Ulcerative Colitis Market
◘ Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging China Ulcerative Colitis Market
◘ Leading company profiles reveal details of key China Ulcerative Colitis Market players emerging five operations and financial performance
◘ Add weight to presentations and pitches by understanding the future growth prospects of the emerging China Ulcerative Colitis Market with five year historical forecasts
◘ Compares data from North America, South America, Asia Pacific Europe and Middle East Africa, alongside individual chapters on each region
The next part also sheds light on the gap between supply and consumption. Apart from the mentioned information, growth rate of China Ulcerative Colitis Market in 2028 is also explained. Additionally, type wise and application wise consumption tables and figures of China Ulcerative Colitis Market are also given.
𝐁𝐮𝐲 𝐓𝐡𝐢𝐬 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐖𝐢𝐭𝐡 𝐅𝐥𝐚𝐭 𝐔𝐒𝐃 𝟐𝟎𝟎𝟎 𝐎𝐟𝐟 @
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 China Ulcerative Colitis Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: China Ulcerative Colitis Industry Impact
Chapter 2 Global China Ulcerative Colitis Competition by Types, Applications, and Top Regions and Countries
2.1 Global China Ulcerative Colitis (Volume and Value) by Type
2.3 Global China Ulcerative Colitis (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global China Ulcerative Colitis Sales, Consumption, Export, Import by Regions
Chapter 5 North America China Ulcerative Colitis Market Analysis
Chapter 6 East Asia China Ulcerative Colitis Market Analysis
Chapter 7 Europe China Ulcerative Colitis Market Analysis
Chapter 8 South Asia China Ulcerative Colitis Market Analysis
Chapter 9 Southeast Asia China Ulcerative Colitis Market Analysis
Chapter 10 Middle East China Ulcerative Colitis Market Analysis
Chapter 11 Africa China Ulcerative Colitis Market Analysis
Chapter 12 Oceania China Ulcerative Colitis Market Analysis
Chapter 13 South America China Ulcerative Colitis Market Analysis
Chapter 14 Company Profiles and Key Figures in China Ulcerative Colitis Business
Chapter 15 Global China Ulcerative Colitis Market Forecast (2022-2028)
Chapter 16 Conclusions
About Coherent Market Insights
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027